CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in AUPH — Aurinia Pharmaceuticals Inc.
CIK 884546
SAN FRANCISCO, CA
Position in AUPH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,568,450
+$723,596 QoQ
Shares Held
445,990
-3.4% QoQ
Ownership
0.335%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 279 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AUPH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. AUPH ranks #115 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in AUPH
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,568,450 | 445,990 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $6,844,854 | 461,866 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,897,864 | 432,468 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,839,314 | 437,947 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $4,334,361 | 511,731 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $4,192,184 | 521,416 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $5,972,481 | 665,087 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $5,453,886 | 744,050 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,734,968 | 654,110 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,700,179 | 538,958 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,939,337 | 438,191 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $2,993,781 | 385,300 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $3,015,842 | 311,554 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,353,584 | 305,984 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,299,088 | 300,715 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,228,183 | 296,301 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,976,820 | 296,201 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||